A carregar...
Nephroprotective effects of GLP-1 receptor agonists: where do we stand?
Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D). These drugs have potent glucose-lowering actions and, additionally, lower body weight through satiety induction while reducing blood pressure and...
Na minha lista:
| Publicado no: | J Nephrol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7560915/ https://ncbi.nlm.nih.gov/pubmed/32356231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40620-020-00738-9 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|